Allegations about Cassava Sciences' Alzheimer's disease treatment have SAVA stock falling today By Nick Clarkson, Web Editor Aug 25, 2021, 1:06 pm EST Shares of Cassava Sciences (NASDAQ: SAVA) stock are getting crushed on Wednesday after some allegations have investors questioning one of the company’s therapeutics.
Full Answer
Why is cassava Sciences (Sava) stock falling?
Apr 05, 2022 · April 5, 2022. Cassava Sciences (NASDAQ: SAVA) stock is falling on Tuesday as investors react to a recent fireside chat from CEO Remi Barbier. Source: Postmodern Studio / Shutterstock.com. Cassava...
Will cassava Sciences stock outperform or underperform the S&P 500 over the long term?
Nov 17, 2021 · Nov. 17, 2021, 02:27 PM. The Wall Street Journal reported that the SEC had launched a probe into claims that Cassava Sciences Inc (NASDAQ: SAVA) manipulated data key to its case for its ...
What do you think about cassava?
Aug 27, 2021 · Shares of Cassava Sciences ( SAVA 4.56%) are falling off a cliff yet again today, down 25% to $53 apiece as of 10:30 a.m. EDT. The company is investigating its lead drug candidate, simufilam, for ...
What was the earnings per share for cassava Sciences?
Nov 17, 2021 · See Why Cassava Sciences Shares Are Falling On Wednesday? The Wall Street Journal reported that the SEC had launched a probe into claims that Cassava Sciences Inc (NASDAQ: SAVA) manipulated data...
Is Cassava Sciences a buy right now?
5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cassava Sciences in the last year. There are currently 1 hold rating and 4 buy ratings for the stock.
What stocks does MarketBeat like better than Cassava Sciences?
Wall Street analysts have given Cassava Sciences a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cassava Sciences wasn't one of them.
Are investors shorting Cassava Sciences?
Cassava Sciences saw a increase in short interest in August. As of August 13th, there was short interest totaling 5,400,000 shares, an increase of 35.0% from the July 29th total of 4,000,000 shares. Based on an average daily volume of 4,190,000 shares, the short-interest ratio is presently 1.3 days.
When is Cassava Sciences' next earnings date?
Cassava Sciences is scheduled to release its next quarterly earnings announcement on Monday, November 8th 2021.#N#View our earnings forecast for Cassava Sciences.
How were Cassava Sciences' earnings last quarter?
Cassava Sciences, Inc. (NASDAQ:SAVA) announced its quarterly earnings results on Tuesday, August, 3rd. The company reported ($0.13) EPS for the quarter, meeting the Zacks' consensus estimate of ($0.13).#N#View Cassava Sciences' earnings history.
How has Cassava Sciences' stock been impacted by Coronavirus?
Cassava Sciences' stock was trading at $4.24 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, SAVA stock has increased by 1,084.0% and is now trading at $50.20.#N#View which stocks have been most impacted by COVID-19.
When did Cassava Sciences' stock split? How did Cassava Sciences' stock split work?
Shares of Cassava Sciences reverse split before market open on Wednesday, May 10th 2017. The 1-7 reverse split was announced on Monday, May 8th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, May 9th 2017.
